Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth N Ross

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Nature|July 14, 2015
Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolismRushika M Perera, Svetlana Stoykova, Brandon N Nicolay, et al.
Nature Cell Biology|April 28, 2015
The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosineJean-Pierre Etchegaray, Lukas Chavez, Yun Huang, et al.
The Journal of Clinical Investigation|September 21, 2010
HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humansSachie Marubayashi, Priya Koppikar, Tony Taldone, et al.
Chemistry & Biology|May 28, 2013
Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiationStacey M Frumm, Zi Peng Fan, Kenneth N Ross, et al.
Molecular Cell|August 11, 2019
The Histone Deacetylase SIRT6 Restrains Transcription Elongation via Promoter-Proximal PausingJean-Pierre Etchegaray, Lei Zhong, Catherine Li, et al.
Science (New York, N.Y.)|September 30, 2006
The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and diseaseJustin Lamb, Emily D Crawford, David Peck, et al.
Nature Cell Biology|January 19, 2023
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcomaDiana Y Lu, Jana M Ellegast, Kenneth N Ross, et al.
Cancer Cell|October 6, 2009
Proteomic and genetic approaches identify Syk as an AML targetCynthia K Hahn, Jacob E Berchuck, Kenneth N Ross, et al.
The Journal of Clinical Investigation|February 14, 2012
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemiaVersha Banerji, Stacey M Frumm, Kenneth N Ross, et al.
Nature Biotechnology|March 2, 2016
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell linesChanning Yu, Aristotle M Mannan, Griselda Metta Yvone, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Nature|July 14, 2015
Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolismRushika M Perera, Svetlana Stoykova, Brandon N Nicolay, et al.
Nature Cell Biology|April 28, 2015
The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosineJean-Pierre Etchegaray, Lukas Chavez, Yun Huang, et al.
The Journal of Clinical Investigation|September 21, 2010
HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humansSachie Marubayashi, Priya Koppikar, Tony Taldone, et al.
Chemistry & Biology|May 28, 2013
Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiationStacey M Frumm, Zi Peng Fan, Kenneth N Ross, et al.
Molecular Cell|August 11, 2019
The Histone Deacetylase SIRT6 Restrains Transcription Elongation via Promoter-Proximal PausingJean-Pierre Etchegaray, Lei Zhong, Catherine Li, et al.
Science (New York, N.Y.)|September 30, 2006
The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and diseaseJustin Lamb, Emily D Crawford, David Peck, et al.
Nature Cell Biology|January 19, 2023
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcomaDiana Y Lu, Jana M Ellegast, Kenneth N Ross, et al.
Cancer Cell|October 6, 2009
Proteomic and genetic approaches identify Syk as an AML targetCynthia K Hahn, Jacob E Berchuck, Kenneth N Ross, et al.
The Journal of Clinical Investigation|February 14, 2012
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemiaVersha Banerji, Stacey M Frumm, Kenneth N Ross, et al.
Nature Biotechnology|March 2, 2016
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell linesChanning Yu, Aristotle M Mannan, Griselda Metta Yvone, et al.
Pageof 4